...
首页> 外文期刊>Diagnostic microbiology and infectious disease >In vitro activity of daptomycin against Staphylococcus aureus and vancomycin-resistant Enterococcus faecium isolates associated with skin and soft tissue infections: first results from India.
【24h】

In vitro activity of daptomycin against Staphylococcus aureus and vancomycin-resistant Enterococcus faecium isolates associated with skin and soft tissue infections: first results from India.

机译:达托霉素针对与皮肤和软组织感染有关的金黄色葡萄球菌和耐万古霉素的粪肠球菌分离株的体外活性:印度的第一个结果。

获取原文
获取原文并翻译 | 示例

摘要

The in vitro activity of daptomycin and selected comparator agents against Staphylococcus aureus and vancomycin-resistant Enterococcus faecium (VREF) isolates recovered from hospitalized patients with skin and soft tissue infection's was evaluated by Clinical and Laboratory Standards Institute broth microdilution method. Daptomycin was the most active agent against both S. aureus (MIC(90), 1 microg/mL; 100% susceptible) and VREF (MIC(90), 4 microg/mL; 100% susceptible), making it an excellent therapeutic option.
机译:通过临床和实验室标准协会肉汤微稀释法评估了达托霉素和所选比较剂对金黄色葡萄球菌和耐万古霉素粪便肠球菌(VREF)分离株的体外活性,所述分离株是从住院的皮肤和软组织感染患者中回收的。达托霉素是针对金黄色葡萄球菌(MIC(90),1 microg / mL; 100%易感)和VREF(MIC(90),4 microg / mL; 100%易感)的活性最高的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号